During the past decade, Newton Wellesley Urology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Newton Wellesley Urology" are "Benign Prostatic Hypertrophy" (1 trials), "Prostatic Hyperplasia" (1 trials), "Prostatic Intraepithelial Neoplasia" (1 trials) and "Urinary Retention" (1 trials). Many other conditions were trialed in "Newton Wellesley Urology" in a lesser frequency.

Most popular intervention types in "Newton Wellesley Urology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alfuzosin (SL770499)" (1 trials) and "GTX-006 (Acapodene)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Newton Wellesley Urology" are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Newton Wellesley Urology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Newton Wellesley Urology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Newton Wellesley Urology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".